Lanxess shares declined roughly 3% after investment bank Goldman Sachs lowered its recommendation on the specialty chemicals maker to Sell from Neutral and reduced its price target to €13 from €21. The downgrade followed the company's first quarter 2026 results, which were released on May 7.
Goldman pointed to company guidance for second quarter 2026 adjusted EBITDA that sat approximately 10% below Visible Alpha Consensus and close to 37% below Goldman Sachs' own estimate. That gap in expectations prompted the firm to reassess the stock's outlook and the margin trajectory for the business.
In February, Goldman had upgraded Lanxess to Neutral on the view that a recovering US manufacturing cycle would support demand. In its reassessment, the bank said that assumption has been overtaken by a broader reset in global energy and chemical prices connected to the Middle East conflict. According to Goldman, the altered price backdrop reduces the prospect of an incremental margin opportunity for the company.
Management's discussion around the Q1 2026 results also factored into Goldman's view. Company commentary indicated that higher selling prices were generally being offset by increased feedstock and energy costs, limiting the potential for margin expansion despite elevated chemical prices.
Goldman analysts summarized their position by noting: "The Middle East conflict has in our view raised the risk of downside volatility without an incremental margin opportunity, and we see the range of outcomes for second half adj. EBITDA skewing flat to negative as customer destocking and demand destruction risks build," reflecting concerns about both margin pressure and demand deterioration.
The market reaction - a single-digit decline in the shares - followed the downgrade and the sharp reduction in Goldman’s price target. The bank's change in stance underscores the tension between selling price dynamics and rising input costs in shaping near-term profitability for firms exposed to energy and chemical price swings.
Key points
- Goldman Sachs downgraded Lanxess to Sell from Neutral and cut its price target to €13 from €21 after Q1 2026 results released on May 7.
- Second quarter 2026 adjusted EBITDA guidance was about 10% below Visible Alpha Consensus and nearly 37% below Goldman Sachs’ estimates.
- Goldman cited a reset in global energy and chemical prices related to the Middle East conflict and noted management said higher selling prices were broadly offset by feedstock and energy costs.
Risks and uncertainties
- Downside volatility in energy and chemical prices linked to geopolitical developments could further pressure margins - affecting the chemicals and industrials sectors.
- Customer destocking and demand destruction pose risks to second half adjusted EBITDA, creating uncertainty around near-term revenue and profit trends in manufacturing and industrial demand chains.